+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bacteriophage Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • ID: 5345596
  • Report
  • May 2021
  • Region: Global
  • 90 pages
  • Acute Market Reports

FEATURED COMPANIES

  • Armata Pharmaceuticals
  • Arthur Andrew Medical
  • Atcc Globa
  • BioChimpharm
  • Intralytix
  • Micreos Human Health
The global bacteriophage market is expected to grow at compound annual growth rate (CAGR) of 4.5%. Raise in incidence of antimicrobial resistance will lead to growth in Bacteriophage market in the upcoming years. According to Centers for disease control & prevention CDC at least 23,000 of people in the United States & around 33,000 people in Europe die due to antibiotic resistant infections. With increasing inpatient care there has been a rise in the adoption of bacteriophage in phage research centers, along with bacteriophage supplements. Bacteriophage is also known as phage therapy and it needs viruses for the medication of bacterial infections. Bacterial viruses are called phages or bacteriophages.

Bacteriophages are supposed to be natural antagonists of bacteria and are found in soil, water, sewage & other places where bacterias are exposed. With the recent advances in technology, particularly the ability to elucidate genome sequences of bacterial hosts, there has been a renewed interest in phages. Traditionally, phages have been considered as a nuisance in the industrial processes that depend on bacterial fermentation. Since the discovery of bacteriophages, many researchers have considered their potential as therapeutic agents. After the World War II, when antibiotics were discovered, the natural potential of bacteriophages received little attention and was considered only as a research tool. Bacteriophages have significantly contributed in the field of biotechnology and molecular biology and are still playing an important role. Today, their potential to be used as phage display systems, antibacterials, vehicles for vaccines and biocontrol agents, and the attention towards bacteriophages is rekindled.

Increasing R&D is Expected to Multiply Revenues

The Bacteriophage market is expected to grow at a significant rate due to rising manufacturing of antibiotic resistant infection, rising research activities for development of therapies, increasing adoption of growth strategies such as acquisitions, and collaborations by market players. Emergence of e-Commerce is increasing the share of pharmaceuticals companies. Most companies are focusing on setting up online stores of Bacteriophage preparations to make phages and phage therapy available across the world. The Bacteriophage must be treated with safety precautions & there is no data related to these methods. . Increasing government funding to support phage therapy manufacturers in developing an innovative approach to decrease antimicrobial-resistant infection cases is anticipated to boost market growth.

Food & Beverages Display Highest Share by Application in Bacteriophage Market

At present food & beverages occupy the largest revenue share in the global bacteriophage market. Bacteriophages find the widest application in food biocontrol and present as a natural and green method that uses lytic bacteriophages derived from the environment to target pathogenic bacteria. Since the initial conception of the use of bacteriophages on foods, additional research are also being conducted for using bacteriophage to target pathogenic bacteria in ready to eat meals, fresh fruits, dairy products and vegetables. This has led to increase in approved products containing bacteriophages for food safety applications. Clinical applications of bacteriophages will witness the fastest market growth during the forecast period. Increased use of bacteriophages in diagnostics, phage display technology and potential use in drug discovery and development are the main attributes to the fast growth of this segment.

North America Remains the Market Leader

Growing failure of antibiotic treatment to fight against infections such as multi-drug resistant Staphylococcus aureus has renewed interest in bacteriophage therapy in countries such as Georgia Poland Russia etc. The U.S. bacteriophage market is expanding due to rising prevalence of antibiotic resistance and increasing demand for an alternative to antibiotics in the country. However, lack of regulatory approval by USFDA for therapeutic bacteriophages is somewhat hampering market expansion in the U.S.

North America held the largest regional market share for bacteriophage market in 2020. Strong desire to overcome the burden of antibiotic-resistant infections, strongly established research infrastructure, and existence of potential pipeline for phage therapy are the key attributes of North America market. Europe is the second largest market for bacteriophage on the grounds of wide application of bacteriophage in food and environmental fields and stable presence of phage therapy in the region. Asia Pacific will witness the fastest progress in the global market. Rapidly evolving biotechnology infrastructure, evolving agriculture practices, and equally supportive government initiatives contribute to the rapid growth of Asia Pacific market.

Key Players and Key Strategies

Key players are adopting growth strategies such as facility expansions, and collaborations and acquisitions to enhance their presence in potential markets, which has expected to rise the market growth over the forecast period. Arthur Andrew Medical, Deerland Probiotics & Enzymes, BioChimpharm, Micreos Human Health, Armata Pharmaceuticals, Pherecydes pharmaceuticals, Adaptive Phage Therapeutics, Intralytix, Phagelux, PhagoMed Biopharma, Atcc Global.

Historical & Forecast Period

This research report presents the analysis of each segment from 2019 to 2029 considering 2020 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segment are calculated for the forecast period from 2021 to 2029.

Key questions answered in this report
  • What are the key market segments in current scenario and in the future by product categories?
  • What are the key market segments in current scenario and in the future by regions?
  • What is the key impact of Covid-19 over market revenues and market determinants in the medical aesthetics market?
  • What are the primary and secondary macro and micro factors influencing the market growth currently and during the forecast period?
  • What are the primary and secondary macro and micro factors deterring the market growth currently and during the forecast period?
  • How to overcome the current market challenges and leverage the opportunities in each of the market segment?
  • Who are the key players in the medical aesthetics market and what are their key product categories and strategies?
  • What are the key strategies - mergers/acquisitions/R&D/strategic partnerships etc, that companies are deploying to enhance market revenues and growth?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Armata Pharmaceuticals
  • Arthur Andrew Medical
  • Atcc Globa
  • BioChimpharm
  • Intralytix
  • Micreos Human Health
Chapter 1. Preface
1.1. Report Description
1.2. Research Scope
1.3. Research Methodology
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Bacteriophage Market Portraiture
2.2. Global Bacteriophage Market, by Bacteria Type, 2020 (US$ Mn)
2.3. Global Bacteriophage Market, by Application, 2020 (US$ Mn)
2.4. Global Bacteriophage Market, By Administration Route type, 2020 (US$ Mn)
2.5. Global Bacteriophage Market, By Covid-19 impact, 2020 - 2021 (US$ Mn)
2.6. Global Bacteriophage Market, by Geography, 2020 (US$ Mn)

Chapter 3. Bacteriophage: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2020
3.6. Competitive Analysis: Global Bacteriophage Market, by Key Players, 2020

Chapter 4. Global Bacteriophage Market, by Bacteria Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Salmonella Bacteriophage
4.3. Streptococcus Bacteriophage
4.4. Escherichia Coli
4.5. Streptococcus & Pseudomonas Bacteriophage

Chapter 5. Global Bacteriophage Market, by Application, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Diagnostic
5.3. Food & Beverages
5.4. Agriculture
5.5. Antimicrobial Drug Discovery
5.6. Veterinary

Chapter 6. Global Bacteriophage Market, by Administration Route type, 2016-2026 (US$ Mn)
6.1. Overview
6.2. Topical
6.3. Intravenous
6.4. Trans nasal
6.5. Oral & trans rectal

Chapter 7. Global Bacteriophage Market, By Covid-19 impact, 2020-2021 (US$ Mn)
7.1. Overview
7.2. Advantages
7.3. Disadvantages

Chapter 8. Global Bacteriophage Market, by Geography, 2016 - 2026 (US$ Mn)
8.1. North America Bacteriophage Market Analysis, 2016 - 2026
8.2. Europe Bacteriophage Market Analysis, 2016 - 2026
8.3. Asia Pacific Bacteriophage Market Analysis, 2016 - 2026
8.4. Latin America Bacteriophage Market Analysis, 2016 - 2026
8.5. Middle East & Africa Bacteriophage Market, 2016 - 2026

Chapter 9. Company Profiles
9.1. AmpliPhi Biosciences Corporation
9.2. Phage Biotech Ltd.
9.3. EnBiotix
9.4. Fixed-Phage Limited
9.5. InnoPhage, Ltd.
9.6. PHERECYDES PHARMA
9.7. TechnoPhage SA
9.8. Federal State Scientific-Industrial Company MICROGEN
9.9. Phage Therapy Center
9.10. VersatileBio
Note: Product cover images may vary from those shown
  • Arthur Andrew Medical
  • Deerland Probiotics & Enzymes
  • BioChimpharm
  • Micreos Human Health
  • Armata Pharmaceuticals
  • Pherecydes pharmaceuticals
  • Adaptive Phage Therapeutics
  • Intralytix
  • Phagelux
  • PhagoMed Biopharma
  • Atcc Globa
Note: Product cover images may vary from those shown
Adroll
adroll